Boji Medical Technology Co.,Ltd. (SHE:300404)
China · Delayed Price · Currency is CNY 10.82
-0.32 (-2.87%)
At close: May 12, 2026
Boji Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 45.47 | 32.91 | 28.78 | 24.34 | 27.67 | 38.88 |
Depreciation & Amortization | 28.14 | 28.14 | 26.77 | 23.25 | 21.5 | 17.88 |
Other Amortization | 7.24 | 7.24 | 4.11 | 4.23 | 2.83 | 1.46 |
Loss (Gain) From Sale of Assets | - | - | 0.21 | 0 | - | - |
Asset Writedown & Restructuring Costs | 8.73 | 8.73 | 0.08 | 0.03 | 0.07 | 0.3 |
Loss (Gain) From Sale of Investments | -0.84 | -0.84 | -3.04 | -2.78 | -3.75 | -2.36 |
Provision & Write-off of Bad Debts | - | - | 20.38 | 15.36 | 14.92 | 8.32 |
Other Operating Activities | -11.01 | 21.51 | 8.58 | 7.62 | 7.27 | 7.79 |
Change in Accounts Receivable | -80.7 | -80.7 | -108.31 | -45.55 | -52.26 | -22.47 |
Change in Inventory | -41.94 | -41.94 | 8.24 | -33.51 | -23.49 | -56.55 |
Change in Accounts Payable | 124.11 | 124.11 | 60.08 | 57.01 | 41.35 | 38.69 |
Operating Cash Flow | 67.05 | 87.01 | 26.78 | 35.95 | 28.14 | 30.1 |
Operating Cash Flow Growth | 30.51% | 224.90% | -25.52% | 27.77% | -6.52% | -68.99% |
Capital Expenditures | -17.85 | -18.71 | -29.35 | -62.2 | -117.73 | -53.99 |
Sale of Property, Plant & Equipment | 0.01 | 0 | 0.46 | 0.01 | 0.01 | 0.11 |
Investment in Securities | 2.23 | 1.59 | -40.98 | 26.42 | -47.71 | -42.13 |
Other Investing Activities | -76.03 | -29.29 | 3.02 | 2.68 | 3.41 | 2.49 |
Investing Cash Flow | -91.64 | -46.4 | -66.85 | -33.1 | -162.02 | -93.52 |
Long-Term Debt Issued | - | 44.69 | 8.33 | 56.02 | 75.31 | 25.13 |
Total Debt Issued | 43.75 | 44.69 | 8.33 | 56.02 | 75.31 | 25.13 |
Long-Term Debt Repaid | - | -45.51 | -75.61 | -27.71 | -28.67 | -33.79 |
Total Debt Repaid | -46.31 | -45.51 | -75.61 | -27.71 | -28.67 | -33.79 |
Net Debt Issued (Repaid) | -2.56 | -0.82 | -67.29 | 28.31 | 46.64 | -8.66 |
Issuance of Common Stock | 21.56 | 26.31 | 3.35 | 94.59 | 12.14 | 348.2 |
Repurchase of Common Stock | - | - | -15.65 | - | - | - |
Common Dividends Paid | -5.83 | -5.92 | -7.58 | -8.04 | -6.84 | -1.2 |
Other Financing Activities | 23.66 | -2.64 | 0.18 | -27.93 | -0.53 | -35.94 |
Financing Cash Flow | 36.83 | 16.93 | -86.98 | 86.93 | 51.41 | 302.4 |
Foreign Exchange Rate Adjustments | -1.11 | -0.66 | 0.46 | 0.45 | 2.88 | -0.84 |
Net Cash Flow | 11.12 | 56.87 | -126.6 | 90.23 | -79.59 | 238.14 |
Free Cash Flow | 49.2 | 68.3 | -2.57 | -26.24 | -89.59 | -23.89 |
Free Cash Flow Margin | 5.18% | 7.86% | -0.35% | -4.72% | -21.15% | -7.37% |
Free Cash Flow Per Share | 0.13 | 0.18 | -0.01 | -0.07 | -0.24 | -0.07 |
Cash Income Tax Paid | 52.33 | 48.13 | 38.96 | 21.67 | 10.19 | 11.85 |
Levered Free Cash Flow | 66.78 | 86.61 | 3.33 | -47.08 | -106.39 | -62.77 |
Unlevered Free Cash Flow | 66.78 | 86.61 | 5.32 | -46.12 | -105.95 | -61.9 |
Change in Working Capital | -10.68 | -10.68 | -59.1 | -36.1 | -42.36 | -42.18 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.